Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
about
Biomarker-Based Approaches for Assessing Alcohol Use DisordersNoninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitusClinical significance of sCD163 and its possible role in asthma (Review).Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferonElevated soluble CD163 plasma levels are associated with disease severity in patients with hemorrhagic fever with renal syndromeSULF2, a heparan sulfate endosulfatase, is present in the blood of healthy individuals and increases in cirrhosis.Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma.Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients.Simian Varicella Virus Is Present in Macrophages, Dendritic Cells, and T Cells in Lymph Nodes of Rhesus Macaques after Experimental Reactivation.Contribution of Hepatitis B to Long-Term Outcome Among Patients With Acute Myocardial Infarction: A Nationwide Study.Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver DiseaseHepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets.Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver diseaseMBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.Chronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activation.Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infectionHigh pathogen burden in childhood promotes the development of unconventional innate-like CD8+ T cells.Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.Organ system view of the hepatic innate immunity in HCV infection.IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men.The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.Complement 5a is an indicator of significant fibrosis and earlier cirrhosis in patients chronically infected with hepatitis B virus.Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury.Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma.Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALTSoluble CD163 is associated with noninvasive measures of liver fibrosis in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected women.Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis.Serum Activity of Macrophage-Derived Adenosine Deaminase 2 Is Associated With Liver Fibrosis in Nonalcoholic Fatty Liver Disease.Editorial: measuring inflammatory and fibrotic components of portal hypertension - a non-invasive hepatic venous pressure gradient? Authors' reply.The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.Introduction to the special issue on the 9th International Congress on Autoimmunity.Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV TherapyHigh hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study
P2860
Q26772931-8116642A-4F0D-491C-B17B-7C5B999A4031Q30397191-FCF686CF-1ECC-48E9-BC8B-79DDF9B45AE9Q33596529-F8B356C7-77C5-4ACD-BA32-D98028C2D83BQ33674640-3C4D907A-23AB-4156-AF48-5F1E3B671C5CQ33877898-158BDC48-8F0A-4DDA-8CC2-3788A0FE176AQ34505966-ABA01F18-CBF5-4636-A6DD-0A3FDF29C0ACQ35009594-35C83322-A658-4D15-8E5F-C637908E5653Q35143602-937C4269-B6CD-4055-8FBE-0CEA295A6B96Q35787865-C8C46901-487D-419A-B1D5-322F62EBDDB2Q36080918-352673F7-EBEA-4939-910F-783C421DC43AQ36566972-E53F3376-0E7B-4503-93D3-0470CC3A4F66Q36751382-1D351033-E498-4231-8AC3-F321CEB1F885Q36947366-F74A9BB6-8F78-4A1F-B7ED-497B7C749AE8Q37057228-1E3BAEE5-367E-4E04-8516-045C6D0E6893Q37264708-4E2FA75B-DAD4-461B-A038-B8C75A1F241FQ37522434-2801A2DD-0177-4A79-8D10-5C2DCEADD6F9Q38282854-F127E896-9BA4-4DA8-8FDD-557EFEE16939Q38645940-4D3FB93B-253D-436A-9A4A-89457055081AQ38675714-D8D020D4-6349-409E-9E3A-77BE85CE505AQ38827613-B2C55BDF-43C1-4514-9AC8-50A0A6F96928Q40258100-A0F5D6FC-05DC-4807-941E-F2735A31C1D9Q40332270-E582C6B6-1824-4082-B1EF-17E1BE18D6F1Q40337789-EF311299-DD10-41E7-B294-B7BBE1780D64Q40548408-867869F8-8905-4577-ACF1-4EBA4961F999Q40556586-B0F69BF4-1689-47B2-8D67-41E1E85F1A68Q40632660-DD48F342-AD0D-4CDA-8C15-2353B550042EQ41139490-31D3E8E2-65BF-4A30-818F-B5F9A36BBBF8Q41219178-E002023C-4CDD-469B-B475-475F5965C3FCQ41992867-484DD835-E14E-4804-905B-8759A654936CQ43102252-0BC24214-6463-4438-BDEA-5159A01CB394Q46232074-40A26A6A-4EDB-4554-8274-C9F91A0CFC1BQ47266129-10B56C95-33A3-44E4-8792-EEF224D17FE2Q47563942-8B1C480A-97CB-48C0-A805-8D80DF96E42DQ47993022-35D25C1D-AACD-42F5-940B-ED8EAD308624Q49693592-364FC1BB-FFA3-407E-9001-78B065C2A1CBQ50237588-C551383D-A31F-4501-863E-525C2A71C3D6Q52873745-95D41D46-16EE-4CCD-80C1-EC1C35CAEC42Q53081134-4CD479E6-B49A-408C-8623-E53BA80A69A8Q58127297-BB3167C6-3376-4172-A587-983945FA673CQ58706878-5713DAA3-0B10-4EDF-BBBB-C5D4E1DE8F89
P2860
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Soluble CD163, a macrophage ac ...... ronic viral hepatitis B and C.
@en
Soluble CD163, a macrophage ac ...... ronic viral hepatitis B and C.
@nl
type
label
Soluble CD163, a macrophage ac ...... ronic viral hepatitis B and C.
@en
Soluble CD163, a macrophage ac ...... ronic viral hepatitis B and C.
@nl
prefLabel
Soluble CD163, a macrophage ac ...... ronic viral hepatitis B and C.
@en
Soluble CD163, a macrophage ac ...... ronic viral hepatitis B and C.
@nl
P2093
P2860
P356
P1433
P1476
Soluble CD163, a macrophage ac ...... ronic viral hepatitis B and C.
@en
P2093
Bo Martin Bibby
Hendrik Vilstrup
Henning Grønbaek
Jacob George
Konstantin Kazankov
P2860
P304
P356
10.1002/HEP.27129
P407
P577
2014-05-06T00:00:00Z